Daidone MG - Search Results

1

Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.

Orlandi R, De Bortoli M, Ciniselli CM, Vaghi E, Caccia D, Garrisi V, Pizzamiglio S, Veneroni S, Bonini C, Agresti R, Daidone MG, Morelli D, Camaschella C, Verderio P, Bongarzone I. Orlandi R, et al. Among authors: daidone mg. Ann Oncol. 2014 Feb;25(2):352-7. doi: 10.1093/annonc/mdt490. Epub 2013 Dec 3. Ann Oncol. 2014. PMID: 24306042 Free article.

2

Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers.

Veneroni S, Zaffaroni N, Daidone MG, Benini E, Villa R, Silvestrini R. Veneroni S, et al. Among authors: daidone mg. Eur J Cancer. 1994;30A(7):1002-7. doi: 10.1016/0959-8049(94)90132-5. Eur J Cancer. 1994. PMID: 7946563

3

p53 as an independent prognostic marker in lymph node-negative breast cancer patients.

Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U. Silvestrini R, et al. Among authors: daidone mg. J Natl Cancer Inst. 1993 Jun 16;85(12):965-70. doi: 10.1093/jnci/85.12.965. J Natl Cancer Inst. 1993. PMID: 8496982

4

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients.

Silvestrini R, Benini E, Veneroni S, Daidone MG, Tomasic G, Squicciarini P, Salvadori B. Silvestrini R, et al. Among authors: daidone mg. J Clin Oncol. 1996 May;14(5):1604-10. doi: 10.1200/JCO.1996.14.5.1604. J Clin Oncol. 1996. PMID: 8622078

5

Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.

Crippa F, Seregni E, Agresti R, Chiesa C, Pascali C, Bogni A, Decise D, De Sanctis V, Greco M, Daidone MG, Bombardieri E. Crippa F, et al. Among authors: daidone mg. Eur J Nucl Med. 1998 Oct;25(10):1429-34. doi: 10.1007/s002590050319. Eur J Nucl Med. 1998. PMID: 9818284 Clinical Trial.

6

Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer.

Daidone MG, Veneroni S, Benini E, Tomasic G, Coradini D, Mastore M, Brambilla C, Ferrari L, Silvestrini R. Daidone MG, et al. Int J Cancer. 1999 Dec 22;84(6):580-6. doi: 10.1002/(sici)1097-0215(19991222)84:6<580::aid-ijc7>3.0.co;2-w. Int J Cancer. 1999. PMID: 10567902 Clinical Trial.

7

Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.

Daidone MG, Luisi A, Veneroni S, Benini E, Silvestrini R. Daidone MG, et al. Endocr Relat Cancer. 1999 Mar;6(1):61-8. doi: 10.1677/erc.0.0060061. Endocr Relat Cancer. 1999. PMID: 10732789 Review.

8

Estrogen receptor-beta expression in hereditary breast cancer.

Daidone MG, Veneroni S, Cappelletti V, Radice P, Pierotti MA, Younes M. Daidone MG, et al. J Clin Oncol. 2002 Sep 1;20(17):3752-3; author reply 3753. doi: 10.1200/JCO.2002.99.116. J Clin Oncol. 2002. PMID: 12202682 No abstract available.

9

Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence.

Coradini D, Pellizzaro C, Veneroni S, Ventura L, Daidone MG. Coradini D, et al. Among authors: daidone mg. Br J Cancer. 2002 Nov 4;87(10):1105-11. doi: 10.1038/sj.bjc.6600556. Br J Cancer. 2002. PMID: 12402149 Free PMC article.

10

Primary breast cancer in elderly women: biological profile and relation with clinical outcome.

Daidone MG, Coradini D, Martelli G, Veneroni S. Daidone MG, et al. Crit Rev Oncol Hematol. 2003 Mar;45(3):313-25. doi: 10.1016/s1040-8428(02)00144-0. Crit Rev Oncol Hematol. 2003. PMID: 12633842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters